PCCM @vumclung, Informatics @vumcdbmi, co-host of @icucast. Views are my own.

Joined February 2013
It was an honor to be invited to speak at #LIVES2023. This is an excellent conference and Milan is a beautiful city.
Now @EdQian presenting the second-last trial of the President’s session: Clinical trials in Intensive Care chaired by @ElieAzoulay5 @criticcaredoc The #ACORNtrial: Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection Published recently in @JAMA_current: jamanetwork.com/journals/jam… #LIVES2023
2
4
37
3,888
In this episode we talk about fevers in patients with acute neurologic injury (INTREPID) AND LTVV in acute neurologic injury (PROLABI). A good one! INTREPID: pubmed.ncbi.nlm.nih.gov/3932… PROLABI: pubmed.ncbi.nlm.nih.gov/3928… Listen anywhere: pod.link/1667336877
2
1
6
1,100
Please just include your email...
Great discussion about two new RCTs. Or if you are burned out on new trials, listen in to learn about the new (appears useless) "fan mail" button that you can use to agitate @EdQian
2
286
Network, learn, and grow at the #CCBootCamp2024 🤝💡. From Evidence-Based ICU Airway Management to Heart Failure in the ICU, get ready for an immersive learning experience. Join us! 🔗 eventbrite.com/e/vumc-critic…
3
1
4
886
We even share some ideas for new analyses that would add to our understanding of the field! Authors, feel free to cite @IcuCast
New episode! Stress steroids in septic shock from CAP, a 2ndary analysis of the APROCCHSS trial in @LancetRespirMed Then we dive into our mailbag and address questions on driving pressure and the timing of intubation! Anywhere you get your podcasts! pod.link/1667336877
3
393
New episode from #ATS2024! We review the presentations from the @NEJM, @JAMA_current, and @ATSBlueEditor combined session. We also talk a little bit about the conference in general and how we're handling the "terrible weather" in San Diego. @ATScritcare  pod.link/1667336877
3
1
10
1,496
It's fascinating reading the landmark articles and getting the idea of the practice at the time that sparked the question. But as times and technology evolve, sometimes we do need to ask ourselves if those old articles still apply, this is a great example. Kudos to the authors!
2
464
Edward Qian retweeted
Have yall seen the #ccbootcamp2024 schedule yet? Can’t wait for these 2 days! @VUMC_OAP @AprilKapu @meg_shifrin @hugt @toddrice_ICU @EdQian @ctbanes @dcm7200
3
3
6
1,901
A little shorter than normal but a good discussion and from a journal we don't typically read which makes it more fun!
4
343
A great experience and fantastic discussion. Thanks for the opportunity!
📣 Webinar recording and slides now available: "Antibiotic Choice on Renal Outcomes – The ACORN Trial" with @EdQian of @VUMChealth 🔗 bit.ly/3PzLfU9 #pctGR
1
8
769
Episode 31! We talk about non-invasive versus invasive blood pressure monitoring from an observational paper by Haber et al from @whcpccm and supplement that discussion with the 65 trial and discuss MAP targets (and how little we know about them!) pod.link/1667336877
4
1
12
2,952
Episode 30! We recap the @SCCM conference THEN discuss PROPHY-VAP from @LancetRespirMed by Prof Dahyot-Fizelier. FINALLY we answer listener questions (and apologies if we butchered some biochemistry in the process...) PROPHY-VAP: pubmed.ncbi.nlm.nih.gov/3826… pod.link/1667336877
1
2
2
13
3,602
What a great listen, this discussion probably comes closest to the actual questions we turned over in the design process. And obviously, @JoannaCCPharmD is a legend.
🚨NEW POD ALERT🚨 Rapid Reaction: ACORN trial Featuring: Michael Behal @MLB_PharmD and Joanna Stollings @JoannaCCPharmD Why is this trial design so unique? ⭐️ Is the AKI question finally answered? 🤔 Can we actually blame the cefepime? 🫤 Trial fun facts 🏅 & much, more! open.spotify.com/show/4zYbVR… podcasts.apple.com/us/podcas… pharmacytodose.com/2024/01/1…
3
12
2,116
Episode 29! We compare the ATS and ESICM guidelines on ARDS management! There are some subtle but key differences and we talk about why that is and where we stand. pod.link/1667336877 ATS: pubmed.ncbi.nlm.nih.gov/3803… ESICM: pubmed.ncbi.nlm.nih.gov/3732… This is a fun episode!
6
1
20
3,003
A little surreal, I definitely leaned on these summaries as a busy trainee (and as an attending). Now the ACORN trial has one. Bravo, thanks for the hard work!
#TBL 443: ACORN - Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection thebottomline.org.uk/summari… Article by @EdQian Review b @hgmwalker89 #FOAMed #FOAMcc #Sepsis
2
16
1,281
Episode 28! Starting the year off with a big ECMO discussion talking about PRONECMO published last month in @JAMA_current and then EOLIA as our old article published 2018 in @NEJM pod.link/1667336877 PRONECMO: pubmed.ncbi.nlm.nih.gov/3803… EOLIA: pubmed.ncbi.nlm.nih.gov/2979…
7
1
23
8,480
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial - @EdQian @toddrice_ICU & colleagues jamanetwork.com/journals/jam… One of our 🔥Top Viewed at JAMA in 2023🔥 Read more “Best of…” here jamanetwork.com/journals/jam…
8
17
2,155